Literature DB >> 12881402

Wound healing is not impaired by the epidermal growth factor receptor-tyrosine kinase inhibitor gefitinib.

R Govindan, D Behnken, W Read, H McLeod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12881402     DOI： 10.1093/annonc/mdg352

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  4 in total

Review 1.  Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients.

Authors:  Devron R Shah; Shamik Dholakia; Rashmi R Shah
Journal:  Drug Saf       Date:  2014-03       Impact factor: 5.606

Review 2.  A comparison of epithelial-to-mesenchymal transition and re-epithelialization.

Authors:  Philip L Leopold; Jan Vincent; Hongjun Wang
Journal:  Semin Cancer Biol       Date:  2012-07-31       Impact factor: 15.707

3.  Effects of an epidermal growth factor receptor-based cancer vaccine on wound healing and inflammation processes in murine experimental models.

Authors:  Dasha Fuentes; Lewis Chacón; Angel Casacó; Nuris Ledón; Nidia Fernández; Arianna Iglesias; Diana R Hernández; Belinda Sánchez; Rolando Pérez
Journal:  Int Wound J       Date:  2012-09-04       Impact factor: 3.315

4.  Lung squamous cell carcinoma with brachial soft tissue metastasis responsive to gefitinib: Report of a rare case.

Authors:  Kana Kataoka; Eiji Osaka; Tetsuo Shimizu; Yuki Okamura; Yukihiro Yoshida; Yasuaki Tokuhashi
Journal:  Thorac Cancer       Date:  2016-06-13       Impact factor: 3.500
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.